These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7074776)

  • 61. Plasma digoxin concentrations in patients with atrial fibrillation.
    Chamberlain DA; White RJ; Howard MR; Smith TW
    Br Med J; 1970 Aug; 3(5720):429-32. PubMed ID: 5454321
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.
    Bianconi L; Mennuni M
    Am J Cardiol; 1998 Sep; 82(5):584-8. PubMed ID: 9732884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Verapamil in atrial fibrillation: The expected, the unexpected, and the unknown.
    Schwartz JB
    Am Heart J; 1983 Jul; 106(1 Pt 1):173-6. PubMed ID: 6869191
    [No Abstract]   [Full Text] [Related]  

  • 64. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation.
    Galun E; Flugelman MY; Glickson M; Eliakim M
    Chest; 1991 Apr; 99(4):1038-40. PubMed ID: 2009763
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Comparison between digoxin and atenolol in chronic atrial fibrillation].
    Lanas F; Salvatici R; Castillo G; Montecinos A; Stockins B; Molina E
    Rev Med Chil; 1995 Oct; 123(10):1252-62. PubMed ID: 8733316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of oral amiodarone in controlling heart rate in patients with persistent atrial fibrillation who have undergone digitalisation.
    Kochiadakis GE; Kanoupakis EM; Igoumenidis NE; Mavrakis HE; Kafarakis PK; Vardas PE
    Hellenic J Cardiol; 2005; 46(5):336-40. PubMed ID: 16295942
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Xamoterol improves the control of chronic atrial fibrillation in elderly patients.
    Lawson-Matthew PJ; McLean KA; Dent M; Austin CA; Channer KS
    Age Ageing; 1995 Jul; 24(4):321-5. PubMed ID: 7484490
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.
    Pinter A; Dorian P; Paquette M; Ng A; Burns M; Spanu I; Freeman M; Korley V; Newman D
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):17-24. PubMed ID: 12652326
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].
    Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A
    Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improved rate control in atrial fibrillation.
    Reiffel JA
    Am Heart J; 1992 Apr; 123(4 Pt 1):1094-8. PubMed ID: 1549987
    [No Abstract]   [Full Text] [Related]  

  • 71. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil.
    Meurling CJ; Ingemansson MP; Roijer A; Carlson J; Lindholm CJ; Smideberg B; Sornmo L; Stridh M; Olsson SB
    Europace; 1999 Oct; 1(4):234-41. PubMed ID: 11220560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Experience with the treatment of atrial fibrillation with cordarone and digoxin].
    Gligan LI; Ol' IV; Shmeleva LA
    Klin Med (Mosk); 1990 Feb; 68(2):46-8. PubMed ID: 2335945
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute atrial fibrillation.
    Freestone B; Kamath S; Lip G
    Clin Evid; 2002 Jun; (7):1-10. PubMed ID: 12230635
    [No Abstract]   [Full Text] [Related]  

  • 74. [Ventricular fibrillation as a result of digoxin and verapamil interaction].
    Banasiak W; Telichowski C; Molenda W; Kupczak K
    Pol Tyg Lek; 1985 Nov; 40(44):1240-1. PubMed ID: 4088942
    [No Abstract]   [Full Text] [Related]  

  • 75. The influence of verapamil on serum digoxin concentration.
    Klein HO; Lang R; Weiss E; Di Segni E; Libhaber C; Guerrero J; Kaplinsky E
    Circulation; 1982 May; 65(5):998-1003. PubMed ID: 7074765
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM; Hille DA; Wachtell K; Kjeldsen SE; Boman K; Dahlöf B; Devereux RB
    J Hypertens; 2015 Jul; 33(7):1480-6. PubMed ID: 25799208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Should chronic atrial fibrillation be treated with digoxin?].
    Garre K
    Ugeskr Laeger; 1990 Aug; 152(35):2475-8. PubMed ID: 1976285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation.
    Kleinbloesem CH; van Brummelen P; Hillers J; Moolenaar AJ; Breimer DD
    Ther Drug Monit; 1985; 7(4):372-6. PubMed ID: 3909533
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral digitalisation: choice of dose.
    Dobbs SM; Parkes J; Rodgers EM; Kenyon WI
    Br Med J; 1977 Jul; 2(6080):168. PubMed ID: 871828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.